发明申请
US20090143383A1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
有权
适用于治疗多巴胺D3受体调节症状的ARYLOXYYHYLAMINE化合物
- 专利标题： ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR
- 专利标题（中）： 适用于治疗多巴胺D3受体调节症状的ARYLOXYYHYLAMINE化合物
-
申请号： US12296739申请日： 2007-04-13
-
公开(公告)号： US20090143383A1公开(公告)日： 2009-06-04
- 发明人: Roland Grandel , Wilfried Martin Braje , Andreas Haupt , Sean Colm Turner , Udo Lange , Karla Drescher , Liliane Unger
- 申请人： Roland Grandel , Wilfried Martin Braje , Andreas Haupt , Sean Colm Turner , Udo Lange , Karla Drescher , Liliane Unger
- 申请人地址： DE Wiesbaden
- 专利权人： Abbott GMBH & Co. KG
- 当前专利权人： Abbott GMBH & Co. KG
- 当前专利权人地址： DE Wiesbaden
- 优先权： EP06007923.3 20060414
- 国际申请： PCT/EP2007/053633 WO 20070413
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D413/02 ; C07D403/02 ; A61K31/44 ; A61K31/506 ; C07D401/02
摘要：
The present invention relates to aryloxyethylamine compounds of the formula I and the physiologically tolerated acid addition salts thereof. The variables have the meanings given in the claims and the description. The invention also relates to the use of a compound of the formula I or a pharmaceutically acceptable salt thereof for preparing a pharmaceutical composition for the treatment of a medical disorder susceptible to treatment with a dopamine D3 receptor ligand.
公开/授权文献
信息查询
IPC分类:
